Bc Snukoil with a partnership coming, record quarterly, positive study results, Patent PR coming, isradipine launching.......and the slim chance of being bought out this year........I'd rather not chase....and at the .30 cent range......still way undervalued for what Nasrat has in store. All of course in my humble opinion based off the honest DD i've done!
Market Data 
Markets 
AI
